Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Explore the detailed record of transactions filed by SICARD JOHN, Director. Director active across 1 company, notably Orthofix Medical Inc.. Aggregated, 3 disclosures have been recorded. History available since 21 June 2021. The latest transaction was filed on 6 June 2022 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
3 of 3 declarations
John Sicard is a Board Member at Orthofix Medical Inc. He contributes to the governance of the company and strategic decision-making. His experience in the medical sector is valuable in guiding the company's initiatives. As a board member, he ensures that Orthofix meets its performance and innovation objectives.